Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 94

1.

Immune-mediated cerebellar ataxias: from bench to bedside.

Mitoma H, Manto M, Hampe CS.

Cerebellum Ataxias. 2017 Sep 21;4:16. doi: 10.1186/s40673-017-0073-7. eCollection 2017. Review.

2.

Neurotransplantation therapy and cerebellar reserve.

Cendelin J, Mitoma H, Manto M.

CNS Neurol Disord Drug Targets. 2017 Aug 10. doi: 10.2174/1871527316666170810114559. [Epub ahead of print]

PMID:
28799490
3.

Quantitative Analysis of Motor Status in Parkinson's Disease Using Wearable Devices: From Methodological Considerations to Problems in Clinical Applications.

Suzuki M, Mitoma H, Yoneyama M.

Parkinsons Dis. 2017;2017:6139716. doi: 10.1155/2017/6139716. Epub 2017 May 18. Review.

4.

Pathogenesis of systemic sclerosis-current concept and emerging treatments.

Furue M, Mitoma C, Mitoma H, Tsuji G, Chiba T, Nakahara T, Uchi H, Kadono T.

Immunol Res. 2017 Aug;65(4):790-797. doi: 10.1007/s12026-017-8926-y. Review.

PMID:
28488090
5.

Pathogenic Roles of Glutamic Acid Decarboxylase 65 Autoantibodies in Cerebellar Ataxias.

Mitoma H, Manto M, Hampe CS.

J Immunol Res. 2017;2017:2913297. doi: 10.1155/2017/2913297. Epub 2017 Mar 12. Review.

6.

The physiological basis of therapies for cerebellar ataxias.

Mitoma H, Manto M.

Ther Adv Neurol Disord. 2016 Sep;9(5):396-413. doi: 10.1177/1756285616648940. Epub 2016 May 20. Review.

7.

Functional interleukin-33 receptors are expressed in early progenitor stages of allergy-related granulocytes.

Tsuzuki H, Arinobu Y, Miyawaki K, Takaki A, Ota SI, Ota Y, Mitoma H, Akahoshi M, Mori Y, Iwasaki H, Niiro H, Tsukamoto H, Akashi K.

Immunology. 2017 Jan;150(1):64-73. doi: 10.1111/imm.12667. Epub 2016 Sep 30.

PMID:
27568595
8.

Molecular mechanisms of action of anti-TNF-α agents - Comparison among therapeutic TNF-α antagonists.

Mitoma H, Horiuchi T, Tsukamoto H, Ueda N.

Cytokine. 2016 Aug 24. pii: S1043-4666(16)30468-9. doi: 10.1016/j.cyto.2016.08.014. [Epub ahead of print]

PMID:
27567553
9.

Prevalence of Autoantibodies and the Efficacy of Immunotherapy for Autoimmune Cerebellar Ataxia.

Nanri K, Okuma M, Sato S, Yoneda M, Taguchi T, Mitoma H, Yamada J, Unezaki S, Nagatani T, Otsubo S, Sugawara M, Tanaka N, Mizusawa H.

Intern Med. 2016;55(5):449-54. doi: 10.2169/internalmedicine.55.5156. Epub 2016 Mar 1.

10.

Guidelines for treatment of immune-mediated cerebellar ataxias.

Mitoma H, Hadjivassiliou M, Honnorat J.

Cerebellum Ataxias. 2015 Nov 10;2:14. doi: 10.1186/s40673-015-0034-y. eCollection 2015. Review.

11.

Overlooked Holmes' clinical signs: reevaluation by recent physiological findings.

Ishikawa T, Kakei S, Mitoma H.

Cerebellum Ataxias. 2015 Nov 6;2:13. doi: 10.1186/s40673-015-0033-z. eCollection 2015.

12.

Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer.

Okugawa Y, Toiyama Y, Toden S, Mitoma H, Nagasaka T, Tanaka K, Inoue Y, Kusunoki M, Boland CR, Goel A.

Gut. 2017 Jan;66(1):107-117. doi: 10.1136/gutjnl-2015-309359. Epub 2015 Oct 15.

PMID:
26475630
13.

Ambulatory Gait Behavior in Patients With Dementia: A Comparison With Parkinson's Disease.

Yoneyama M, Mitoma H, Sanjo N, Higuma M, Terashi H, Yokota T.

IEEE Trans Neural Syst Rehabil Eng. 2016 Aug;24(8):817-26. doi: 10.1109/TNSRE.2015.2477856. Epub 2015 Sep 11.

PMID:
26372429
14.

Increased CD226 Expression on CD8+ T Cells Is Associated with Upregulated Cytokine Production and Endothelial Cell Injury in Patients with Systemic Sclerosis.

Ayano M, Tsukamoto H, Kohno K, Ueda N, Tanaka A, Mitoma H, Akahoshi M, Arinobu Y, Niiro H, Horiuchi T, Akashi K.

J Immunol. 2015 Aug 1;195(3):892-900. doi: 10.4049/jimmunol.1403046. Epub 2015 Jun 24.

15.

Quality of life in Japanese female patients with systemic lupus erythematosus: Evaluation using the Short Form 36 Health Survey.

Furukawa M, Kiyohara C, Horiuchi T, Tsukamoto H, Mitoma H, Kimoto Y, Uchino A, Nakagawa M, Oryoji K, Shimoda T, Akashi K.

Mod Rheumatol. 2016;26(2):240-7. doi: 10.3109/14397595.2015.1060668. Epub 2015 Jul 20.

PMID:
26054420
16.

Serum progranulin levels are elevated in dermatomyositis patients with acute interstitial lung disease, predicting prognosis.

Tanaka A, Tsukamoto H, Mitoma H, Kiyohara C, Ueda N, Ayano M, Ohta S, Kimoto Y, Akahoshi M, Arinobu Y, Niiro H, Tada Y, Horiuchi T, Akashi K.

Arthritis Res Ther. 2015 Feb 10;17:27. doi: 10.1186/s13075-015-0547-z.

17.

Disease-specific monoclonal antibodies targeting glutamate decarboxylase impair GABAergic neurotransmission and affect motor learning and behavioral functions.

Manto M, Honnorat J, Hampe CS, Guerra-Narbona R, López-Ramos JC, Delgado-García JM, Saitow F, Suzuki H, Yanagawa Y, Mizusawa H, Mitoma H.

Front Behav Neurosci. 2015 Mar 27;9:78. doi: 10.3389/fnbeh.2015.00078. eCollection 2015.

18.

Consensus Paper: Neuroimmune Mechanisms of Cerebellar Ataxias.

Mitoma H, Adhikari K, Aeschlimann D, Chattopadhyay P, Hadjivassiliou M, Hampe CS, Honnorat J, Joubert B, Kakei S, Lee J, Manto M, Matsunaga A, Mizusawa H, Nanri K, Shanmugarajah P, Yoneda M, Yuki N.

Cerebellum. 2016 Apr;15(2):213-32. doi: 10.1007/s12311-015-0664-x. Review.

19.

Generation mechanism of RANKL(+) effector memory B cells: relevance to the pathogenesis of rheumatoid arthritis.

Ota Y, Niiro H, Ota S, Ueki N, Tsuzuki H, Nakayama T, Mishima K, Higashioka K, Jabbarzadeh-Tabrizi S, Mitoma H, Akahoshi M, Arinobu Y, Kukita A, Yamada H, Tsukamoto H, Akashi K.

Arthritis Res Ther. 2016 Mar 16;18:67. doi: 10.1186/s13075-016-0957-6.

20.

Human NLRP3 inflammasome senses multiple types of bacterial RNAs.

Sha W, Mitoma H, Hanabuchi S, Bao M, Weng L, Sugimoto N, Liu Y, Zhang Z, Zhong J, Sun B, Liu YJ.

Proc Natl Acad Sci U S A. 2014 Nov 11;111(45):16059-64. doi: 10.1073/pnas.1412487111. Epub 2014 Oct 29.

Supplemental Content

Loading ...
Support Center